Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.
Anxiety disorders
Brief psychological treatments
Cost-benefit analysis
Depression
Emotional disorders
Primary care
Randomized controlled trial
Somatoform disorders
Transdiagnostic therapy
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
09 02 2022
09 02 2022
Historique:
received:
10
01
2022
accepted:
22
01
2022
entrez:
10
2
2022
pubmed:
11
2
2022
medline:
15
2
2022
Statut:
epublish
Résumé
Emotional disorders are common, and they have become more prevalent since the COVID-19 pandemic. Due to a high attendance burden at the specialized level, most emotional disorders in Spain are treated in primary care, where they are usually misdiagnosed and treated using psychotropic drugs. This contributes to perpetuate their illness and increase health care costs. Following the IAPT programme and the transdiagnostic approach, the PsicAP project developed a brief group transdiagnostic cognitive-behavioural therapy (tCBT) as a cost-effective alternative. However, it is not suitable for everyone; in some cases, one-on-one sessions may be more effective. The objective of the present study is to compare, in cost-benefit terms, group and individual tCBT with the treatment usually administered in Spanish primary care (TAU). A randomized, controlled, multicentre, and single-blinded trial will be performed. Adults with mild to moderate emotional disorders will be recruited and placed in one of three arms: group tCBT, individual tCBT, or TAU. Medical data and outcomes regarding emotional symptoms, disability, quality of life, and emotion regulation biases will be collected at baseline, immediately after treatment, and 6 and 12 months later. The data will be used to calculate incremental cost-effectiveness and cost-utility ratios. This trial aims to contribute to clinical practice research. The involvement of psychologists in primary care and the implementation of a stepped-care model for mental disorders are recommended. Group therapy and a transdiagnostic approach may help optimize health system resources and unblock waiting lists so that people can spend less time experiencing mental health problems. ClinicalTrials.gov: NCT04847310; Protocols.io: bx2npqde. (April 19, 2021).
Sections du résumé
BACKGROUND
Emotional disorders are common, and they have become more prevalent since the COVID-19 pandemic. Due to a high attendance burden at the specialized level, most emotional disorders in Spain are treated in primary care, where they are usually misdiagnosed and treated using psychotropic drugs. This contributes to perpetuate their illness and increase health care costs. Following the IAPT programme and the transdiagnostic approach, the PsicAP project developed a brief group transdiagnostic cognitive-behavioural therapy (tCBT) as a cost-effective alternative. However, it is not suitable for everyone; in some cases, one-on-one sessions may be more effective. The objective of the present study is to compare, in cost-benefit terms, group and individual tCBT with the treatment usually administered in Spanish primary care (TAU).
METHODS
A randomized, controlled, multicentre, and single-blinded trial will be performed. Adults with mild to moderate emotional disorders will be recruited and placed in one of three arms: group tCBT, individual tCBT, or TAU. Medical data and outcomes regarding emotional symptoms, disability, quality of life, and emotion regulation biases will be collected at baseline, immediately after treatment, and 6 and 12 months later. The data will be used to calculate incremental cost-effectiveness and cost-utility ratios.
DISCUSSION
This trial aims to contribute to clinical practice research. The involvement of psychologists in primary care and the implementation of a stepped-care model for mental disorders are recommended. Group therapy and a transdiagnostic approach may help optimize health system resources and unblock waiting lists so that people can spend less time experiencing mental health problems.
TRIAL REGISTRATION
ClinicalTrials.gov: NCT04847310; Protocols.io: bx2npqde. (April 19, 2021).
Identifiants
pubmed: 35139809
doi: 10.1186/s12888-022-03726-4
pii: 10.1186/s12888-022-03726-4
pmc: PMC8826705
doi:
Banques de données
ClinicalTrials.gov
['NCT04847310']
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
99Subventions
Organisme : Agencia Estatal de Investigación
ID : PID2019-107243RB-C22
Informations de copyright
© 2022. The Author(s).
Références
Psychother Res. 2021 Jul 16;:1-14
pubmed: 34269640
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Behav Ther. 2019 Mar;50(2):257-269
pubmed: 30824244
J Anxiety Disord. 2006;20(8):1036-54
pubmed: 16387472
J Clin Psychiatry. 2013 Jun;74(6):595-602
pubmed: 23842011
World Psychiatry. 2013 Jun;12(2):137-48
pubmed: 23737423
J Affect Disord. 2018 Jul;234:247-255
pubmed: 29549826
Arch Gen Psychiatry. 2004 Mar;61(3):310-7
pubmed: 14993119
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
J Anxiety Disord. 1997 May-Jun;11(3):279-96
pubmed: 9220301
J Affect Disord. 2013 Oct;151(1):313-20
pubmed: 23866301
Depress Anxiety. 2015 Jul;32(7):471-84
pubmed: 25826526
Behav Res Ther. 2004 Apr;42(4):385-96
pubmed: 14998733
BMC Psychiatry. 2016 Feb 27;16:52
pubmed: 26920578
Clin Psychol Rev. 2021 Jul;87:101999
pubmed: 34098412
Behav Res Ther. 1990;28(6):487-95
pubmed: 2076086
Clin Psychol Rev. 2010 Mar;30(2):217-37
pubmed: 20015584
BMC Med. 2010 Jun 25;8:38
pubmed: 20579335
Br J Clin Psychol. 2021 Mar;60(1):1-37
pubmed: 32578231
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
J Affect Disord. 2015 Apr 1;175:152-67
pubmed: 25618002
Assessment. 2013 Apr;20(2):253-61
pubmed: 21467092
Actas Esp Psiquiatr. 2010 Nov-Dec;38(6):345-57
pubmed: 21188674
PLoS One. 2016 Aug 15;11(8):e0161145
pubmed: 27525977
Br J Clin Psychol. 1988 Feb;27(1):99-104
pubmed: 3355911
J Anxiety Disord. 2017 Mar;46:11-24
pubmed: 27466074
Qual Life Res. 2012 Feb;21(1):161-5
pubmed: 21611868
Med Clin (Barc). 1999;112 Suppl 1:79-85
pubmed: 10618804
Ann Fam Med. 2009 May-Jun;7(3):232-8
pubmed: 19433840
Psychosom Med. 2001 Jul-Aug;63(4):679-86
pubmed: 11485122
JMIR Res Protoc. 2016 Dec 23;5(4):e246
pubmed: 28011446
Psychosom Med. 2002 Mar-Apr;64(2):258-66
pubmed: 11914441
J Pers Soc Psychol. 1991 Jul;61(1):115-21
pubmed: 1890582
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Lancet. 2009 Aug 22;374(9690):609-19
pubmed: 19640579
Soc Sci Med. 1998 Jun;46(12):1569-85
pubmed: 9672396
Clin Psychol Rev. 2020 Dec;82:101921
pubmed: 33069096
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Psychiatry Res. 2017 Oct;256:312-317
pubmed: 28666201
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Span J Psychol. 2013;16:E95
pubmed: 24230958
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Annu Rev Clin Psychol. 2018 May 7;14:159-183
pubmed: 29350997
Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95
pubmed: 8923116
Int J Clin Health Psychol. 2021 Jan-Apr;21(1):100203
pubmed: 33363586
J Abnorm Psychol. 1971 Aug;78(1):107-26
pubmed: 4938262
Front Psychol. 2019 Jan 08;9:2674
pubmed: 30671005
Curr Psychiatry Rep. 2019 Nov 23;21(12):129
pubmed: 31760505
Span J Psychol. 2021 Feb 08;24:e8
pubmed: 33551011
Psychother Psychosom. 2020;89(2):90-105
pubmed: 31794968
Australas Psychiatry. 2016 Oct;24(5):489-92
pubmed: 27034440
Psychol Med. 2021 Feb 08;:1-13
pubmed: 33550995
J Eval Clin Pract. 2010 Oct;16(5):895-901
pubmed: 20626541
Health Qual Life Outcomes. 2010 Jan 20;8:8
pubmed: 20089179
Eur Neuropsychopharmacol. 2005 Aug;15(4):357-76
pubmed: 15961293
Med Clin (Barc). 1999 Apr 24;112(14):530-8
pubmed: 10363239
Br J Psychiatry. 2012 Mar;200(3):184-90
pubmed: 22383765
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Eur Psychiatry. 2017 Sep;45:139-153
pubmed: 28763680
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Affect Disord. 2011 Apr;130(1-2):260-7
pubmed: 21075451
J Psychosom Res. 2016 Jan;80:1-10
pubmed: 26721541
BMC Psychiatry. 2017 Aug 9;17(1):291
pubmed: 28793892
Med Decis Making. 2012 Jan-Feb;32(1):41-55
pubmed: 21825270
Gac Sanit. 2020;34 Suppl 1:20-26
pubmed: 32843196
Clin Psychol Rev. 2015 Aug;40:91-110
pubmed: 26094079